swg_tdr, you probably noticed this point:
The 3 percent, three-year hurdle is substantial and generally tougher than the S.E.C.’s original proposal.
All companies, large and small, have a three year wait before the new provisions go into effect. That places the time line beyond the timing at which current PPHM trials are scheduled to be complete and reported out. Three years could even be sufficient time for PPHM/Garnick to delivery some level of Bavi FDA approval. We shall see.
It would seem that "buzzing the Board" has been selected as the focal point for voicing dissatisfaction as PPHM has announced their proxy and approaches the October Annual Share Holder Meeting. Whatever......
Best wishes and IMO.
KT
News 
Market Data 
Discover 
AI
